-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MezNVLtTcbdz5SALNSL4IMZKQURU9zCXB7Z2v0z33VZPqf4LZX8mVVW3A+IBL4pW 8b98EbwL2oxsMVFsg14TPQ== 0001012975-10-000280.txt : 20100818 0001012975-10-000280.hdr.sgml : 20100818 20100818173009 ACCESSION NUMBER: 0001012975-10-000280 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100816 FILED AS OF DATE: 20100818 DATE AS OF CHANGE: 20100818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHAMBON PHILIPPE CENTRAL INDEX KEY: 0001192212 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51567 FILM NUMBER: 101026391 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NxStage Medical, Inc. CENTRAL INDEX KEY: 0001333170 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043454702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 439 SOUTH UNION STREET STREET 2: 5TH FLOOR CITY: LAWRENCE STATE: MA ZIP: 01843 BUSINESS PHONE: 978-687-4700 MAIL ADDRESS: STREET 1: 439 SOUTH UNION STREET STREET 2: 5TH FLOOR CITY: LAWRENCE STATE: MA ZIP: 01843 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-08-16 0001333170 NxStage Medical, Inc. NXTM 0001192212 CHAMBON PHILIPPE C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 1 0 0 0 Common Stock 2010-08-16 4 S 0 100000 17.01 D 5428833 I See footnotes See Footnote 1 in Exhibit 99.1 See Footnote 2 in Exhibit 99.1 See Footnote 3 in Exhibit 99.1 /s/ Craig L. Slutzkin as Attorney-in-fact for Philippe Chambon 2010-08-18 EX-99 2 attach_1.htm
Exhibit 99.1



(1)  Dr. Philippe Chambon ("Chambon"), in his capacity as a member of the investment

committees of DLJCC (as defined below) and of DLJLBO (as defined below), may be deemed to

beneficially own the shares as to which this Form 4 relates. Dr. Chambon disclaims

beneficial ownership of such shares except to the extent of his pecuniary interest therein.



Sprout Capital IX, L.P. ("Sprout IX"), Sprout Capital VIII, L.P. ("Sprout VIII"), Sprout

Capital VII, L.P. ("Sprout VII"), Sprout CEO Fund, L.P. ("Sprout CEO"), Sprout Entrepreneurs

Fund, L.P. ("Sprout Entrepreneurs"), Sprout IX Plan Investors, L.P. ("IX Plan"), Sprout Plan

Investors, L.P. ("Plan Investors"), Sprout Venture Capital, L.P. ("Sprout Venture") and DLJ

ESC II, L.P. ("ESC II") are Delaware limited partnerships which make investments for long

term appreciation. DLJ Capital Corporation ("DLJCC"), a Delaware corporation acts as a

venture capital partnership management company. DLJCC is also the general partner of Sprout

CEO, Sprout Entrepreneurs and Sprout Venture. DLJCC is also the managing general partner of

Sprout IX, Sprout VIII, Sprout VII and, as such, is responsible for their day-to-day

management. DLJCC makes all of the investment decisions on behalf of Sprout IX, Sprout VIII,

Sprout VII, Sprout CEO, Sprout Entrepreneurs and Sprout Venture. DLJ Associates IX, L.P.

("Associates IX"), a Delaware limited partnership, is a general partner of Sprout IX and in

accordance with the terms of the relevant partnership agreement, does not participate in

investment decisions made on behalf of Sprout IX. DLJ Capital Associates IX, Inc. ("DLJCA

IX"), a Delaware corporation, is the managing general partner of Associates IX. DLJ

Associates VIII, L.P. ("Associates VIII"), a Delaware limited partnership, is a general

partner of Sprout VIII and in accordance with the terms of the relevant partnership

agreement, does not participate in investment decisions made on behalf of Sprout VIII. DLJ

Capital Associates VIII, Inc. ("DLJCA VIII"), a Delaware corporation, is the managing

general partner of Associates VIII. DLJ Associates VII, L.P. ("Associates VII"), a Delaware

limited partnership, is a general partner of Sprout VII and in accordance with the terms of

the relevant partnership agreement, does not participate in investment decisions made on

behalf of Sprout VII. DLJ Capital Associates VII, Inc. ("DLJCA VII"), a Delaware

corporation, is the managing general partner of Associates VII. Dr. Chambon is a limited

partner of Associates IX, Associates VIII and Associates VII. DLJ LBO Plans Management

Corporation II ("DLJLBO"), a Delaware corporation, is the general partner of IX Plan and

Plan Investors and, as such, is responsible for each of their day-to-day management. DLJLBO

makes all of the investment decisions on behalf of IX Plan and Plan Investors.



(2) Includes  (i) 61,647 shares of Common Stock sold by Sprout VIII, (ii) 24,285 shares of

Common Stock sold by Sprout VII, (iii) 283 shares of Common Stock sold by Sprout CEO, (iv)

1,380 shares of Common Stock sold by Plan Investors, (v) 3,700 shares of Common Stock sold

by Sprout Venture, (vi) 3,962 shares of Common Stock sold by ESC II and (vii) 4,743 shares

of Common Stock sold by DLJCC.



(3) Includes  (i) 1,531,595 shares of Common Stock held directly by Sprout VIII, (ii)

603,356 shares of Common Stock held directly by Sprout VII, (iii) 7,022 shares of Common

Stock held directly by Sprout CEO, (iv) 34,295 shares of Common Stock held directly by Plan

Investors, (v) 91,919 shares of Common Stock held directly by Sprout Venture, (vi) 98,433

shares of Common Stock held directly by ESC II, (vii) 2,768,323 shares of Common Stock held

directly by Sprout IX, (viii) 11,030 shares of Common Stock held directly by Sprout

Entrepreneurs, (ix) 131,474 shares of Common Stock held directly by IX Plan, (x) 117,835

shares of Common Stock held directly by DLJCC and (xi) 33,551 shares of Common Stock held

directly by Chambon.

-----END PRIVACY-ENHANCED MESSAGE-----